hMPV

R&D

Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.

News

Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.